Almost all prostate cancers respond to androgen deprivation treatment but many recur. We postulated that risk of hormone escape--frequency and delay--are influenced by hormone therapy modalities. More. hormone therapies induce crucial biological changes involving androgen receptors; some might be targets for escape prevention. https://www.jmannino.com/hot-save-POWER-SW-BOARD-ASSY-P000662240-hot-choice/